Platinum-resistant Ovarian Cancer Recruiting Phase 1 Trials for Doxorubicin (DB00997)

Also known as: Platinum drug resistant Ovarian cancer / Platinum-resistant Ovarian Cancer (PROC) / Platinum Resistant Ovarian Cancer

IndicationStatusPhase
DBCOND0068919 (Platinum-resistant Ovarian Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03542669Study of 6b11-OCIK Injection Treatment in Patients With Recurrent Drug-resistant Ovarian CancerTreatment